Introducing XIENCE Skypoint™ Stent 4.5 MM and 5.0 MM Sizes, to Treat Large Vessels
XIENCE Skypoint™ Stent delivers the broadest expansion range in the latest generation XIENCE™ Stent, the DES that consistently delivers successful outcomes—not only in the cath-lab, but far beyond. Now available with 4.5 mm and 5.0 mm sizes.2
Treat a Wide Range of Large Vessel Lesions With XIENCE Skypoint™ Stents4
XIENCE Skypoint™ Stent offers a range of stent lengths from 12 mm to 33 mm to help treat a wide range of patients.4
12 mm
to
33 mm
Stent Diameter
Stent Length
12 mm
15 mm
18 mm
23 mm
28 mm
33 mm
Maximum Expansion
4.5 mm
✓
✓
✓
✓
✓
✓
5.75 mm
5.0 mm
✓
✓
✓
✓
✓
✓
5.75 mm
XIENCE Skypoint™ Stent Supports Accurate Stent Placement Through Precise Stent and Marker Placement5
Accurate mid-marker placement enables precise scaffolding and reduces the likelihood of geographic miss to support optimal patient outcomes.5,6
XIENCE Skypoint™ Stent has Significantly Better Longitudinal Strength Than Other DES in Large Vessels7
Longitudinal strength supports better scaffolding in large coronary vessels. Less stent deformation delivers better patient outcomes.8
XIENCE Skypoint™ Stent Shows Significantly Less Stent Deformation Than Synergy‡ and Resolute Onyx‡ – 5.0 mm Stents
*Denotes significantly different when compared with XIENCE Skypoint™ Stent.
XIENCE™ Stent Shows Improvements in Measures of Quality of Life (QoL) in Patients With Left Main Lesions at 3 Years9
PCI With XIENCE™ Stent in patients with left main lesions showed sustained improvements in QoL out to 3 years9
SAQ - Quality of Life*
*Quality of life is a subscale of the Seattle Angina Questionnaire (SAQ). Scores for each subscale range from 0 to 100 with higher scores representing better health status. Comparison is made Vs baseline.
** Denotes statistically significant difference from baseline.
Frequency of Angina-Free Incidences as Measured by SAQ – AF*
* Frequency of Angina is a subscale of the Seattle Angina Questionnaire (SAQ). Comparison is made vs baseline.
** Denotes statistically significant difference from baseline.
XIENCE™ Stent shows significantly lower definite stent thrombosis rates than Synergy‡ in patients with left main lesions at 2 years10
XIENCE Skypoint™ Stent Instructions For Use (IFU). Refer to IFU for additional information.
XIENCE Skypoint™ Stent – Instructions for Use (IFU). Refer to IFU for additional information. Zanchin, C. et al. J Am Coll Cardiol Intv. 2019;12(17):1665-1675. Serruys P, et al. N Engl J Med. 2010;363:136-146. Kufner S, et al. Circulation. 2019:139(3):325-333.
Data on file at Abbott.
XIENCE Skypoint™ Stent – Instructions for Use (IFU). Refer to IFU for additional information.
Data on file at Abbott. XIENCE Skypoint™ Stent vs. Synergy‡ and Resolute Onyx‡ – 5.0 x 18 or 20 mm stents tested.
Costa M, et al. Am J Cardiol. 2008;101:1704-1711; Sudhir, K., et al. ISRN Cardiology. 2013:1-8.
Data on file at Abbott. XIENCE Skypoint™ Stent – 5.0 x 33 mm, n=5. Synergy‡ 5.0 x 32 mm, n=2. Resolute Onyx‡ – 5.0 x 33 mm , n=5. *Denotes significantly different when compared with XIENCE Skypoint™ Stent. Longitudinal stent compression test was done using 50 gf load.
Shand J, et al. Interv Cardiol. 2012;4:325-335.
Baron S, et al. J Am Coll Cardiol. 2017;70:3113-3122.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
